TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.
about
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyImmunocompromised and immunocompetent mouse models for head and neck squamous cell carcinomaDisseminated tumor cells and dormancy in prostate cancer metastasisRecapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture ModelsGlioblastoma Circulating Cells: Reality, Trap or Illusion?Mechanisms of disseminated cancer cell dormancy: an awakening fieldCancer Cell Colonisation in the Bone MicroenvironmentTumor cell dormancyMetastatic colonization by circulating tumour cellsRole of TGFβ in regulation of the tumor microenvironment and drug delivery (review)EMT, CTCs and CSCs in tumor relapse and drug-resistanceBlockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cellsStress signaling and the shaping of the mammary tissue in development and cancer.Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevanceIntegration of microenvironmental and stress signaling antagonizes colorectal cancer progression.NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes.Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy.Cellular Adhesion Promotes Prostate Cancer Cells Escape from DormancyTβRIII Expression in Human Breast Cancer Stroma and the Role of Soluble TβRIII in Breast Cancer Associated Fibroblasts.Bone metastasis and the metastatic niche.Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cellsCurrent and emerging therapies for bone metastatic castration-resistant prostate cancer.Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.Metastasis prevention by targeting the dormant niche.Osteoclasts-Key Players in Skeletal Health and Disease.Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.TGF-β1 and TGF-β2 abundance in liver diseases of mice and menAxl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.The metastatic cycle: metastatic niches and cancer cell dissemination.Biology, detection, and clinical implications of circulating tumor cells.Microenvironment in metastasis: roadblocks and supportive niches.Matters of context guide future research in TGFβ superfamily signaling.The biology and clinical implications of prostate cancer dormancy and metastasis.Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.Systemic Problems: A perspective on stem cell aging and rejuvenation.
P2860
Q26740207-C3B03A31-4DE6-4A2C-8FF1-F119313EAEF0Q26766538-FEE56050-244A-4F1D-82E2-93C10966C47BQ26768484-613C645A-7459-4103-B5E0-C45F8E6F7F92Q26797285-2C559F01-2006-4706-8A6A-1F2F67089D66Q26823823-158B2BA8-C70A-40C9-96A1-AE0386CB7B41Q27027015-F26C8A4C-CA38-45DB-9F24-6F5FF2BA7A15Q28072561-BE184D62-6B9D-4DA3-8D9E-988B3E13D891Q28073065-4C3D5A00-B18E-458F-8339-5B2D58E2B35EQ28076164-E02C3335-08C9-42EB-B975-F969136BAD8AQ28081170-C11C1B31-6EAD-4811-918A-D5E64F177F9AQ28082935-BA9D3E85-CC9D-42AC-8497-E7518847AB31Q33702231-8C8F376A-6D51-41B6-A6E3-A5737A3FB2F1Q33896062-E9F299A7-6059-420F-9911-E4FB2B31AE2DQ33975619-FC68EDEE-404F-4179-BF2D-F06BCE763FBBQ34332372-645C90A7-452D-4589-8F19-E50D66818FBEQ35037151-64D1EF10-E1EA-4641-B4C6-53E7F261146AQ35666361-AFE9C579-E5EE-4B61-B983-2A79467BFAABQ35668319-289FA591-D0C4-432D-9FDB-274CB073B3F1Q36186532-B7657B29-1EF6-4285-9728-D7D1132A8398Q36259458-D47E8190-4DB3-4657-AC19-9C089C1FCAD2Q36288896-F89C7296-B0B2-48FC-AF6C-F87693495A21Q36358303-983C7ED0-2CA9-4389-9A03-9F67B73DDC66Q36413760-9EF14D03-AE02-4121-9729-732C274EAA4EQ36731080-2DF07988-BBF4-418A-A0DD-A9C61F7EDCA5Q36829245-CEF2931D-4C52-4510-A3F4-BF12DEE9F5FCQ37036135-86597B2C-495A-4C02-A668-B97A18191320Q37167096-6EDBC83E-B71C-46F5-AE9A-33317EB0682EQ37190089-9D86E19D-AFDA-46BC-99A8-8BDEC7A70081Q37397455-F0CEEA43-B26A-4845-A211-6A73113C3711Q37520184-E97D3EA7-E8FE-41B0-8CF6-0B3A62EC9138Q37565470-A26F9DE3-C3D8-47FA-8F32-BEFF005EBD29Q37710308-9293CF0C-D5CE-48DD-8EC6-56EEA5CE8C5CQ38213416-B9CCEDB3-F0A6-4739-AC0A-D57CC4CD99C2Q38259362-85F96093-F888-4733-8D36-077A6F435BA9Q38268371-6DF27E3A-37D2-4A62-8821-FF1DA4990F7CQ38588066-95E09077-2329-4F04-A87E-F94455053B3AQ38612468-FBD89466-4CCD-4D44-A2C8-09A370E64140Q38613304-1441E473-00B5-4EA9-A0A2-35141AA7EBABQ38619615-BC33C3B1-7F8E-444B-87BE-18BC651F3091Q38625964-3BCD483F-97F0-4FB2-9E01-E134EF57F0AF
P2860
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TGF-β2 dictates disseminated t ...... -β-RIII and p38α/β signalling.
@en
TGF-β2 dictates disseminated t ...... -β-RIII and p38α/β signalling.
@nl
type
label
TGF-β2 dictates disseminated t ...... -β-RIII and p38α/β signalling.
@en
TGF-β2 dictates disseminated t ...... -β-RIII and p38α/β signalling.
@nl
prefLabel
TGF-β2 dictates disseminated t ...... -β-RIII and p38α/β signalling.
@en
TGF-β2 dictates disseminated t ...... -β-RIII and p38α/β signalling.
@nl
P2093
P2860
P356
P1433
P1476
TGF-β2 dictates disseminated t ...... F-β-RIII and p38α/β signalling
@en
P2093
Carla Capobianco
Denis M Schewe
Falguni Parikh
Hernan G Farina
Sarah Krause
Yeriel Estrada
P2860
P2888
P304
P356
10.1038/NCB2861
P577
2013-10-27T00:00:00Z